
Liquidity, historical trends, and peer comparisons.
According to ENDRA Life Sciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.10. This represents a change of 174.65% compared to the average of 2.59 of the last 4 quarters.
The mean historical Current Ratio of ENDRA Life Sciences Inc. over the last ten years is 4.88. The current 7.10 Current Ratio has changed 45.44% with respect to the historical average. Over the past ten years (40 quarters), NDRA's Current Ratio was at its highest in in the June 2017 quarter at 47.27. The Current Ratio was at its lowest in in the March 2017 quarter at 0.14.
Average
4.88
Median
5.34
Minimum
0.14
Maximum
8.32
Discovering the peaks and valleys of ENDRA Life Sciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.81%
Maximum Annual Current Ratio = 8.32
Minimum Annual Increase = -77.28%
Minimum Annual Current Ratio = 0.14
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 1.29 | -77.28% |
| 2024 | 5.67 | 68.94% |
| 2023 | 3.36 | -32.90% |
| 2022 | 5.00 | -36.12% |
| 2021 | 7.83 | -5.82% |
| 2020 | 8.32 | 163.85% |
| 2019 | 3.15 | -55.79% |
| 2018 | 7.13 | 2.83% |
| 2017 | 6.93 | 4.81% |
| 2016 | 0.14 | -73.62% |
The current Current Ratio of ENDRA Life Sciences Inc. (NDRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.44
5-year avg
4.63
10-year avg
4.88
ENDRA Life Sciences Inc.’s Current Ratio is greater than BNB Plus Corp. (1.82), greater than Venus Concept Inc. (0.90), less than Bone Biologics Corporation (13.38), greater than NanoVibronix, Inc. (0.66), greater than iSpecimen Inc. (0.82), greater than Corvex, Inc. (1.80), greater than GlucoTrack, Inc. (0.46), greater than HeartSciences Inc. (0.12), greater than DIH Holding US, Inc. (0.49), less than Bio Green Med Solution, Inc. (8.63),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.82 | $1.17M | |
| 0.90 | $578.19K | |
| 13.38 | $1.25M | |
| 0.66 | $1.51M | |
| 0.82 | $2.09M | |
| 1.80 | $203.69M | |
| 0.46 | $223.48K | |
| 0.12 | $15.60M | |
| 0.49 | $209.00 | |
| 8.63 | $5.16M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ENDRA Life Sciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ENDRA Life Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ENDRA Life Sciences Inc.'s Current Ratio?
How is the Current Ratio calculated for ENDRA Life Sciences Inc. (NDRA)?
What is the highest Current Ratio for ENDRA Life Sciences Inc. (NDRA)?
What is the 3-year average Current Ratio for ENDRA Life Sciences Inc. (NDRA)?
What is the 5-year average Current Ratio for ENDRA Life Sciences Inc. (NDRA)?
How does the current Current Ratio for ENDRA Life Sciences Inc. (NDRA) compare to its historical average?